Drugs.com - Pharma Industry News

AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors

TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR) solid tumors, according to a study published online April 27 in the...

Apr 29, 2025 - 18:55
 0
AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR) solid tumors, according to a study published online April 27 in the...
Read More

Tags:

Previous Article

AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer

Next Article

AACR: Pretrained Machine Learning Models Help Diagnose Nonmelanoma Skin Cancer

Related Posts

Proinflammatory Diet Tied to Higher Risk for Chronic Kidney Disease

Proinflammatory Diet Tied to Higher Risk for Chronic Ki...

Apr 23, 2025  0

CDC Provides Update on Measles Outbreak in the United States

CDC Provides Update on Measles Outbreak in the United S...

Apr 30, 2025  0

Outcomes With Immune Checkpoint Inhibitors Similar for Older, Younger Patients

Outcomes With Immune Checkpoint Inhibitors Similar for ...

Apr 29, 2025  0